Form 4: Huntington Bancshares Director Tate Acquires Shares

Sentiment:

Insider Transaction Report


Huntington Bancshares Director Jeffrey L. Tate acquired additional common stock, including shares through a deferred compensation plan, with a transaction date of October 1, 2025.

Summary

  • Jeffrey L. Tate, a Director of Huntington Bancshares Inc. (HBAN), acquired additional shares of common stock.
  • On October 1, 2025, Tate directly acquired 461.241 shares of common stock at a price of $0.00 per share.
  • On the same date, Tate indirectly acquired 45.238 shares of common stock through a Director Deferred Compensation Plan, also at $0.00 per share.
  • Following these transactions, Tate's direct beneficial ownership stands at 112,657.268 shares, and indirect beneficial ownership through the deferred compensation plan is 5,063.708 shares.
  • A Substitute Power of Attorney was filed, appointing Rachel L. Lawless, Robert Matthew Pearson, and Virginia L. Mockler as attorneys-in-fact for Section 16 filings on behalf of Jeffrey L. Tate, effective September 30, 2025.

Sentiment

Score: 7

Explanation: The acquisition of additional shares by a director, even at a $0.00 price (indicating compensation), is generally viewed positively as it increases insider ownership and aligns management interests with shareholders. It's a routine compensation event, not a major market-moving announcement.

Positives

  • Director Jeffrey L. Tate increased his beneficial ownership in Huntington Bancshares Inc. through the acquisition of 506.479 shares (461.241 direct + 45.238 indirect).
  • The acquisitions, made at a price of $0.00 per share, likely represent equity compensation or awards, aligning the director's interests with long-term shareholder value.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

  • The filing includes a standard disclaimer that the statement shall not be construed as an admission that the undersigned is the beneficial owner of the securities for Section 16 purposes.

Industry Context

This Form 4 filing details an individual director's equity compensation and ownership changes, which is a routine disclosure for publicly traded companies in the financial services industry. It does not provide broader insights into industry trends or competitive landscape.

Comparison to Industry Standards

  • This filing reports a standard equity compensation award to a director, a common practice across publicly traded companies, including those in the banking sector.
  • The acquisition of shares at $0.00 is typical for restricted stock units or performance share awards, which are prevalent forms of executive and director compensation designed to align interests with shareholders.
  • No specific comparable companies or projects are mentioned in the filing.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Attorney-in-Fact for Section 16 filingsAnne C. KrugerRachel L. Lawless, Robert Matthew Pearson, Virginia L. Mockler2025-09-30Substitution of attorneys-in-fact under an existing Power of Attorney.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of AttorneyA Substitute Power of Attorney was filed, appointing Rachel L. Lawless, Robert Matthew Pearson, and Virginia L. Mockler as substitute attorneys-in-fact for Jeffrey L. Tate to execute and file Section 16 reports (Forms 3, 4, and 5). This replaces Anne C. Kruger in this capacity.2025-09-30Enhances the administrative efficiency and legal compliance for Section 16 filings by the director, ensuring continuity in reporting obligations.

Related Party Transactions

  • The acquisition of common stock by Director Jeffrey L. Tate from Huntington Bancshares Inc. at $0.00 per share represents an equity compensation award, which is a common form of related party transaction between a company and its directors.

Stakeholder Impact

  • Shareholders: Increased insider ownership by a director may be seen as a positive signal, aligning management interests with shareholder value.

Key Dates

DateDescription
2025-09-30Effective date of the Substitute Power of Attorney appointing new attorneys-in-fact for Section 16 filings.
2025-10-01Date of transaction for the acquisition of common stock by Jeffrey L. Tate.
2025-10-03Date the Form 4 was signed by the attorney-in-fact.

Keywords

Huntington Bancshares, HBAN, Jeffrey L. Tate, Director, Insider Transaction, Form 4, Stock Acquisition, Deferred Compensation, Equity Compensation, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.